Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-16-001

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

Closed on September 26, 2016.

Posted
December 9, 2015
Close date
September 26, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
18
18 new
Median first-year cost
$228,213
$4,097,521 in all
Institutions
16
18 contact PIs
Patents
7
from 5 funded projects

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CHICAGO2
  2. UNIVERSITY OF MICHIGAN AT ANN ARBOR2
  3. BOSTON CHILDREN'S HOSPITAL1
  4. BROWN UNIVERSITY1
  5. JOHNS HOPKINS UNIVERSITY1

and 11 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 TCRB-D (O1))8
  2. Special Emphasis Panel (ZCA1 TCRB-Q (M3))7
  3. Special Emphasis Panel (ZCA1 TCRB-T (J1))3
18 awards under RFA-CA-16-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2017Nanoneedle microrobots for single cancer cell manipulation and genome editing1R21CA212731-01Davis, Ronald WayneSTANFORD UNIVERSITY, CAFirst-year cost $314,000Study section ZCA1
FY2017High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer1R21CA212718-01Van Dam, Robert MichaelUNIVERSITY OF CALIFORNIA LOS ANGELES, CAFirst-year cost $308,000Study section ZCA1
FY2017Single-molecule mechanical detection of protein and microRNA cancer biomarkers1R21CA212827-01Wong, Wesley PhilipBOSTON CHILDREN'S HOSPITAL, MAFirst-year cost $267,258Study section ZCA1
FY2017A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases1R21CA214299-01Slater, John HundleyUNIVERSITY OF DELAWARE, DEFirst-year cost $240,785Study section ZCA1
FY2017uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells1R21CA212958-01Keshari, Kayvan RSLOAN-KETTERING INST CAN RESEARCH, NYFirst-year cost $234,200Study section ZCA1
FY2017rePPI-i: A system for the rapid continuous evolution of protein-protein interaction inhibitors1R21CA217754-01Dickinson, BryanUNIVERSITY OF CHICAGO, ILFirst-year cost $232,874Study section ZCA1
FY2017Single-molecule counting of cancer biomarker miRNAs in human biofluids1R21CA204560-01A1Walter, Nils GUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $232,500Study section ZCA1
FY2017A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors1R21CA217695-01Levinson, Nicholas MarkUNIVERSITY OF MINNESOTA, MNFirst-year cost $229,625Study section ZCA1
FY2017A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS1R21CA212726-01A1Naegle, Kristen MWASHINGTON UNIVERSITY, MOFirst-year cost $228,750Study section ZCA1
FY2017A Target-Directed Reagent Pipeline via Microfluidic mRNA Display1R21CA204708-01A1Malmstadt, NoahRoberts, Richard WUNIVERSITY OF SOUTHERN CALIFORNIA, CAFirst-year cost $227,675Study section ZCA1
FY2017Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications1R21CA212500-01Mohs, Aaron M.UNIVERSITY OF NEBRASKA MEDICAL CENTER, NEFirst-year cost $225,750Study section ZCA1
FY2017The GOF Mutant p53 Beacon System1R21CA212967-01Deb, SumitraWindle, Brad E.VIRGINIA COMMONWEALTH UNIVERSITY, VAFirst-year cost $223,150Study section ZCA1
FY2017Tag-ChIP-MS for analysis of chromatin-level regulation of DNA repair1R21CA213247-01Kron, Stephen J.UNIVERSITY OF CHICAGO, ILFirst-year cost $201,875Study section ZCA1
FY2017Engineered regulation of tyrosine phosphatase activity in living cells1R21CA212907-01A1Karginov, Andrei VUNIVERSITY OF ILLINOIS AT CHICAGO, ILFirst-year cost $199,875Study section ZCA1
FY2017Exquisitely selective turn-on probes of kinase activation and localization1R21CA214233-01Soellner, Matthew BUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $193,750Study section ZCA1
FY2017High resolution cell lineage tracking and isolation1R21CA212928-01A1Brock, AmyUNIVERSITY OF TEXAS AT AUSTIN, TXFirst-year cost $188,280Study section ZCA1
FY2017High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy1R21CA212932-01A1Wong, Ian YBROWN UNIVERSITY, RIFirst-year cost $185,674Study section ZCA1
FY2017High-efficiency microfluidic-assisted single-cell DNA methylome sequencing1R21CA212495-01A1Easwaran, HariharanPisanic Ii, Thomas RussellJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $163,500Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

7 patents name 5 of the 18 funded projects. The newest 5, by patent number.

  1. US 12,564,840 (opens the patent at USPTO, a PDF, in a new tab)HIGH THROUGHPUT RADIOCHEMISTRY SYSTEMGranted March 3, 2026 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR21CA212718 · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA
  2. US 12,078,625 (opens the patent at USPTO, a PDF, in a new tab)SYSTEM AND METHOD FOR HIGH-THROUGHPUT RADIO THIN LAYER CHROMATOGRAPHY ANALYSISGranted September 3, 2024 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR21CA212718 · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA
  3. US 12,077,741 (opens the patent at USPTO, a PDF, in a new tab)Crosslinked Hydrogel Composition for Regulating States of Encapsulated Cancer CellsGranted September 3, 2024 to University Of DelawareR21CA214299 · UNIVERSITY OF DELAWARE, DE
  4. US 11,591,636 (opens the patent at USPTO, a PDF, in a new tab)FORCE-CONTROLLED NANOSWITCH ASSAYS FOR SINGLE-MOLECULE DETECTION IN COMPLEX BIOLOGICAL FLUIDSGranted February 28, 2023 to Children's Medical Center CorporationR21CA212827 · BOSTON CHILDREN'S HOSPITAL, MA
  5. US 11,383,235 (opens the patent at USPTO, a PDF, in a new tab)DEVICE AND METHOD FOR MICROSCALE CHEMICAL REACTIONSGranted July 12, 2022 to THE REGENTS OF THE UNIVERSITY OF CALIFORNIAR21CA212718 · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-20-0.3.9. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-16-001: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) | ConductScience ScienceDex